These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23810077)

  • 41. Improving patient outcomes in schizophrenia: achieving remission.
    Nasrallah HA; Lasser R
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):57-61. PubMed ID: 17046987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adherence predicts symptomatic and psychosocial remission in schizophrenia: Naturalistic study of patient integration in the community.
    Bernardo M; Cañas F; Herrera B; García Dorado M
    Rev Psiquiatr Salud Ment; 2017; 10(3):149-159. PubMed ID: 27291833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term symptomatic remission of schizophrenia with once-daily extended release quetiapine fumarate: post-hoc analysis of data from a randomized withdrawal, placebo-controlled study.
    Peuskens J; Trivedi JK; Brecher M; Miller F;
    Int Clin Psychopharmacol; 2010 May; 25(3):183-7. PubMed ID: 20216222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples.
    Nuechterlein KH; Miklowitz DJ; Ventura J; Gitlin MJ; Stoddard M; Lukoff D
    Psychiatry Res; 2006 Nov; 144(2-3):153-66. PubMed ID: 17011635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Remission in schizophrenia: results from a 1-year follow-up observational study.
    Ciudad A; Alvarez E; Bobes J; San L; Polavieja P; Gilaberte I
    Schizophr Res; 2009 Mar; 108(1-3):214-22. PubMed ID: 19168329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective study.
    Helldin L; Kane JM; Hjärthag F; Norlander T
    Schizophr Res; 2009 Nov; 115(1):67-73. PubMed ID: 19666215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia.
    Kim SW; Yoon JS; Kim YS; Ahn YM; Kim CE; Go HJ; Chee IS; Jung SW; Chung YC; Kim YD; Joe S; Lee J; Kwon YJ; Yoon BH; Jae YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):228-35. PubMed ID: 22516251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcome of suicidal patients with schizophrenia: results from a naturalistic study.
    Schennach-Wolff R; Jäger M; Seemüller F; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ; Riedel M
    Acta Psychiatr Scand; 2010 May; 121(5):359-70. PubMed ID: 19878135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia.
    Karow A; Moritz S; Lambert M; Schöttle D; Naber D;
    Eur Psychiatry; 2012 Aug; 27(6):401-5. PubMed ID: 21570262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional remission and employment among patients with schizophrenia in Malaysia.
    Dahlan R; Midin M; Shah SA; Nik Jaafar NR; Abdul Rahman FN; Baharudin A; Das S; Sidi H
    Compr Psychiatry; 2014 Jan; 55 Suppl 1():S46-51. PubMed ID: 23679983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Remission and recovery: new hopes--realistic aims in the therapy for schizophrenia].
    Schöttle D; Naber D
    Fortschr Neurol Psychiatr; 2014 Apr; 82(4):220-7. PubMed ID: 24710678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Setting new standards in schizophrenia outcomes: symptomatic remission 3 years before versus after the Andreasen criteria.
    Gorwood P; Peuskens J;
    Eur Psychiatry; 2012 Apr; 27(3):170-5. PubMed ID: 21641777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Remission criteria for schizophrenia: evaluation in a large naturalistic cohort.
    De Hert M; van Winkel R; Wampers M; Kane J; van Os J; Peuskens J
    Schizophr Res; 2007 May; 92(1-3):68-73. PubMed ID: 17336500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What could be learned from a decade with standardized remission criteria in schizophrenia spectrum disorders: An exploratory follow-up study.
    Johansson M; Hjärthag F; Helldin L
    Schizophr Res; 2018 May; 195():103-109. PubMed ID: 28899583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measuring remission in schizophrenia: response to Sethuraman et al., 2005.
    Kujawa M; Bossie CA; Lasser RA
    Schizophr Res; 2006 Mar; 83(1):109-10. PubMed ID: 16423505
    [No Abstract]   [Full Text] [Related]  

  • 57. Symptomatic remission affects employment outcomes in schizophrenia patients.
    Wang SP; Wang JD; Chang JH; Wu BJ; Wang TJ; Sun HJ
    BMC Psychiatry; 2020 May; 20(1):219. PubMed ID: 32398138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Seventeen-year clinical outcome of schizophrenia in Bali.
    Kurihara T; Kato M; Reverger R; Tirta IG
    Eur Psychiatry; 2011; 26(5):333-8. PubMed ID: 21696927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Symptomatic remission in a multiracial urban population of older adults with schizophrenia.
    Bankole A; Cohen CI; Vahia I; Diwan S; Palekar N; Reyes P; Sapra M; Ramirez PM
    Am J Geriatr Psychiatry; 2008 Dec; 16(12):966-73. PubMed ID: 19038895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Remission in schizophrenia: proposed criteria and rationale for consensus.
    Andreasen NC; Carpenter WT; Kane JM; Lasser RA; Marder SR; Weinberger DR
    Am J Psychiatry; 2005 Mar; 162(3):441-9. PubMed ID: 15741458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.